Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | Patent Publication Number 20170157101
US 20170157101 A1Publication DateJun 8, 2017
Original AssigneePfizer
Current AssigneeGlobal Blood Therapeutics Inc.
Inventor/ApplicantsEleanor L. Ramos
Athiwat Hutchaleelaha
Joshua Eli Lehrer-Graiwer
Athiwat Hutchaleelaha
Joshua Eli Lehrer-Graiwer
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.